Our Location

304 North Cardinal St.
Dorchester Center, MA 02124


Product Name: Elopag

Strength: 50mg

Volume: 28 tablet

To order: +8801304498958


Package Insert of Elopag-50mg-Eltrombopag

Description | Elopag-50mg-Eltrombopag

Elopag-50mg-Eltrombopag is used to treat low blood platelet counts in adults. Who have chronic immune thrombocytopenia (ITP). ITP is a condition that can cause unusual bleeding or bruising and bleeding happens due to an abnormally lower number of platelets in the blood. Eltrombopag is used to increase the platelet number to reduce the risk of bleeding. In addition this is also used to treat children with one year or older than that. Eltrombopag has also been approved for treating thrombocytopenia in patients with chronic hepatitis C. Besides it allows them to initiate and maintain interferon-based therapy. Elopag-50mg is used after a gastrectomy and other medications have not worked well enough.

Indications for Elopag-50mg-Eltrombopag

Elopag-50mg is a medication for the treatment of chronic thrombocytopenia or in the case of lower blood platelet count. It is also used to treat Primary immune thrombocytopenia (PITP) in adults and children 1 year of age and older. And Chronic hepatitis C (CHC)-associated thrombocytopenia in adults. Some times it is used  to treat refractory severe aplastic anemia (SAA) in adults.

Elopag-50mg can also be used in combination with other medications to treat certain types of leukemia.

 Mechanism of Action of Elopag-50mg-Eltrombopag

Elopag-50mg is a small-molecule TPO-receptor agonist. It  interacts with the human TPO-receptor. After interacting with human TPO receptor it stimulates STAT and JAK phosphorylation. It does not activate the AKT pathway, unlike recombinant TPO or romiplostim. When it is given to patients with aplastic anemia, it increases other lineages besides platelet count. suggesting it enhances the effect of TPO in vivo or has a yet-uncovered mechanism of action.

Eltrombopag stimulates the bone marrow to produce more platelets. It helps to prevent bleeding problems in those with thrombocytopenia. It is used in the first-line treatment of severe aplastic anemia in adults and children.

Dosage and administration of Elopag-50mg-Eltrombopag:

  1. For Chronic immune thrombocytopenia (ITP): The typical initial dose is 50mg once daily. It can be exceptional based on your platelet count response, your healthcare provider may adjust the dosage in every 2 weeks. It can be 25mg to 50mg, up to a maximum dose of 75mg once daily.
  2. For Chronic hepatitis C-associated thrombocytopenia: The usual starting dose is 50mg once daily. Depending on your platelet count response, your healthcare provider may adjust the dosage in every 2 weeks. It can be of 25mg or 50mg, up to a maximum dose of 100mg once daily.

Side Effects of Eltrombopag

A medicine may cause some unwanted side effects, which may require medical attention. Common side effects include
  • bloating,
  • swelling,
  • body pain,
  • difficulty breathing,
  • fever,
  • headache,
  • loss of voice,
  • chest pain.

Less common side effects include

  • bladder pain,
  • blindness,
  • blurred vision,
  • itching,
  • numbness,
  • diarrhea,
  • and general discomfort.

These side effects may go away during treatment as the body adjusts to the medicine. Health care professionals may also provide information on preventing or reducing these side effects. If any side effects persist or are bothersome, consult with your doctor if you have any questions or concerns.

 Eltrombopag Price

The price of eltrombopag can vary depending on the dosage form, the number of tablets, and your insurance coverage. However, it can be expensive, costing several thousand dollars per month.

But Elopag-50mg is cheaper than any other version of Eltrombopag. It has similar efficiency. To order  Elopag-50mg contact with us.

Approval of Eltrombopag by FDA

Eltrombopag was first approved by the FDA in 2008 for the treatment of ITP. It was subsequently approved for the treatment of PITP in 2011, CHC-associated thrombocytopenia in 2013, and SAA in 2015.

Eltrombopag in Dengue

Eltrombopag, a thrombopoietin receptor agonist, is being explored as a potential treatment for dengue fever, a mosquito-borne viral infection that can cause severe bleeding. It works by stimulating platelet production in the bone marrow, increasing platelet counts and reducing bleeding risk. Clinical trials have shown promising results, with one trial showing erombopaglt’s effectiveness in increasing platelet counts and reducing bleeding risk. However, more research is needed to confirm its safety and efficacy.Elopag-50mg is not currently approved by the US FDA for dengue fever treatment, but it is being used in countries where it is available due to the lack of other effective treatments. Side effects include diarrhea, nausea, headache, liver damage, and heart problems.

Eltrombopag in Aplastic Anemia

Elopag-50mg is a thrombopoietin receptor agonist (TPO-RA) that is used to treat aplastic anemia. It is a rare blood disorder that causes the bone marrow to produce too few blood cells. It works by stimulating the production of platelets in the bone marrow. This can help to increase platelet counts and reduce the risk of bleeding in patients with aplastic anemia.

Eltrombopag Myelodysplastic Syndrome

Clinical trials have evaluated the safety and efficacy of Elopag-50mg in treating MDS patients. However, the results have been mixed, with some trials showing it increases platelet counts but doesn’t improve overall survival.

Another trial showed it reduces platelet transfusion need, but more research is needed.

FDA did not approve eltrombopag for MDS treatment. Some countries use this due to the lack of other effective treatments.

Eltrombopag Clinical trials

In clinical trials, Eltrombopag has shown an effective result. It is very useful medication to treat leukemia than other leukemia medications.

Eltrombopag brand name

The brand name of eltrombopag is Promacta. It is available as a tablet and oral suspension.

 It is also marketed in other countries under the brand name Revolade.

See our other Products, bevixa Elbonix-25, Avalet-20mg, Palbonix100/125mg, Ventoxen-100mg, Ibruxen-140mg.

FAQs about Elopag-50mg:

Q: What is Elopag-50mg-Eltrombopag?

A: Elopag-50mg-Eltrombopag is a medication containing the active ingredient Eltrombopag. It is prescribed to stimulate platelet production in individuals with conditions such as chronic immune thrombocytopenia (ITP) or chronic hepatitis C-associated thrombocytopenia.

Q: How does Elopag-50mg-Eltrombopag work?

A: Elopag-50mg-Eltrombopag works by interacting with the body’s natural processes to stimulate the production of platelets in the bone marrow. It helps increase platelet counts, reducing the risk of bleeding and improving clotting ability.

Q: How long does it take for Elopag-50mg-Eltrombopag to show results?

A: The timeframe for experiencing noticeable results may vary among individuals. Some patients may see an improvement in platelet counts within a few weeks of starting Elopag-50mg-Eltrombopag, while others may require a longer duration. It is essential to continue taking the medication as prescribed and follow up with your healthcare provider for monitoring and adjustments.

Q: Are there any side effects associated with Elopag-50mg-Eltrombopag?

A: Like any medication, Elopag-50mg-Eltrombopag may have potential side effects. Common side effects may include nausea, headache, fatigue, muscle or joint pain, and changes in liver function tests. However, not everyone experiences these side effects. It is important to discuss any concerns or unexpected symptoms with your healthcare provider.

Q: Can I take other medications along with Elopag-50mg-Eltrombopag?

A: It is important to inform your healthcare provider about all medications, supplements, or herbal products you are taking. Some medications may interact with Elopag-50mg-Eltrombopag, potentially affecting its effectiveness or increasing the risk of side effects. Your healthcare provider will assess the compatibility and guide you on any necessary precautions.

Contact us for ordering medicines

Whats app and WeChat: +8801304498958

Facebook: Meds for cancer


There are no reviews yet.

Be the first to review “Elopag-50mg-Eltrombopag”